29 jul. órgão emissor: ANVISA – Agência Nacional de Vigilância Sanitária na forma da Lei n° , de 20 de agosto de , sujeitando o infrator. Relevant documents: (1) Brazilian Official Journal (Diário Oficial da Uniăo) Nº page 42, (2)Law , 20 August (Lei nº , de 20 de. Saúde Pública, Rio de Janeiro, 23(6), jun, . ; National Health Surveillance Secretariat (SNVS) Important health control legislation enacted, still in force (Acts 5,/73, 6,/76, and 6,/77 .. Lei no . Cria a Agência Nacional de Vi- gilância Sanitária, define o Sistema Nacional de Vi-.
|Published (Last):||16 August 2007|
|PDF File Size:||3.63 Mb|
|ePub File Size:||20.73 Mb|
|Price:||Free* [*Free Regsitration Required]|
Revista Brasileira de Oftalmologia. However, it could be argued that accepting free samples or not has no effective significance with regard to changing prescriptions; or that distribution of gifts is irrelevant; or that the harassment by marketing agents has the single purpose of publicizing studies that have been conducted and updating physicians regarding innovations, given that it is the industry that invests in technology; or that what is more relevant is the quantity of systematized evidence that the advertising provides, thereby supplying a scientific basis for changing prescriptions.
lei no de 20 de agosto de pdf to excel – PDF Files
Here, a special reference should be made regarding this form of advertising: Rather, the focus here is on advertising that ought leei be directed exclusively towards physicians but improperly reaches medical students. Could there in fact be a reason for advocating prohibition of contacts between marketing agents and physicians?
Leia na Palavra do Presidente. Because of this, these authors emphasized that it is important se physicians qualified professionals to explain the potential conflicts of interest in developing and publishing their clinical studies.
Diário das Leis – Portal de Legislação
In a study on the results from interactions between pharmaceutical representatives and the teachers and physicians of the clinical body, Lurie et al. The impact 4637 individual characteristics in selfesteem and locus of control of young adults with visual impairments. In addition to advertising carried in publications destined for physicians, information dde medications is carried in therapeutic guides.
Association between competing interests and authors’ conclusions: On the other hand, there are marketing agents equipped with ed information that is objective but not always reliable, as we are seeing and correlates a product directly with a disease, with the promise of curing it or controlling it. The importance that the pharmaceutical industry bestows on advertising its products is expressed in the distribution of its expenditure.
Social support and depression of adults with visual impairments. Nonetheless, these are not the only desirable or necessary actions. According to their investigations, the data contained in the tables of the published papers were consistent, but the analyses of these same tables were biased.
In this regard, we present two pieces of convergent information, albeit from different sources. Their conclusions led them to recommend that readers and professionals undertaking peer review tasks should remain attentive with regard to comparisons between data presented in tables and analyses on these data by authors.
This paper identifies and discusses some ethical and legal questions relating to promotion and advertising of medications within environments where medicine is taught. Researchers funded by the pharmaceutical industry may introduce interpretation bias into their analyses that possibly will not be noticed by specialist reviewers, and evidence of this is already available. However, other studies have revealed that accepting presents and hospitality from the pharmaceutical industry may compromise physicians’ judgement regarding medical information and subsequent decisions about patient care.
Rigorous criteria for ethical advertising of these products also need to be established among the professionals. In addition, PMAC has a self-regulation code for its representatives’ activities, sample distribution and event support, among other activities relating to promotion of new medications PMAC Code of Marketing Practices.
Evidence presented in various studies conducted in Brazil and abroad provide the empirical basis for the arguments developed here. Controlled drugs can only be advertised to professionals who are licensed to prescribe 6347 dispense them. Global estimates of visual impairment: Maria Helena Lino participated in the bibliographic review in relation to the juridical aspects of the topic and their incorporation into the body of the paper, and participated in the revision of the li draft.
Inin New Zealand which, like the United States, does not have any restrictions on direct advertising of medications to consumersthe medical schools released a report that advocated ending advertising within their environments and warned 1977 the need to stand up to the power of the pharmaceutical industry, in order to defend the public interest, which is an intrinsic characteristic of State action Toop et al.
lei no 6437 de 20 de agosto de 1977 pdf to excel
Although these authors were not in favor of any control over contacts between pharmaceutical representatives and students, they believed that such contacts would affect their actions as prescribers of medications in the future. Personal use of drug samples by physicians and office staff. The current and erroneous opinion among physicians is that pharmaceutical representatives provide accurate information about their drugs and are capable of providing accurate information on the existing or alternative drugs.
The CFM also ensured that any possible advertisements would not be interpreted as endorsements for any product advertised, and highlighted its concern regarding the potential conflicts of interest associated with clinical practice and research.
In the following, a little of what has been published on this topic around the world will be examined. Promotion and advertising of medications and self-regulation Although advertising of medications and other health-related products has specific features, in a general manner it has the same objective as any other advertising: Advertising and marketing techniques influence individuals’ choices, and the use of these techniques, together with economic power, may give rise to abuses and distortions in commercial practices.
Criteria for medicinal drug promotion resolution WHA All of this information is released for the purpose of identifying probable errors, minimizing difficulties, and suggesting changes to improve the system governing corneal transplants in the country.
It concludes that self-regulation of drug advertising is not justified and that there is sufficient evidence showing how the power of the pharmaceutical industry is capable of influencing decisions made within the physician-patient relationship, in which promotion and advertising are among the tools used.